
Bayer Takes Legal Battle to the Supreme Court Over Roundup Litigation
In a continuation of its complex legal saga, Bayer AG has officially appealed to the United States Supreme Court concerning its ongoing Roundup litigation. This critical move comes as the company seeks to challenge a series of legal decisions that have held it accountable for claims linking its popular herbicide to severe health issues, including cancer.
Continue reading
Bayer Faces $2 Billion Jury Verdict Over Roundup Cancer Claims in Georgia
In a significant legal setback, Bayer AG has been ordered by a jury in Georgia to pay $2 billion in damages to a couple who alleged that their cancer was caused by the company's glyphosate-based herbicide, Roundup. The verdict follows a trial that highlighted the contentious and ongoing debate surrounding the safety of glyphosate, a chemical that has been under scrutiny due to its potential link to cancer.
Continue reading
Bayer Pursues Capital Raise Amidst Ongoing Legal Challenges
Bayer AG, the German pharmaceutical giant, is taking significant steps to manage its extensive legal challenges by seeking regulatory approval for a substantial capital increase. This decision comes as the company continues to face the financial repercussions from various lawsuits related to its herbicide Roundup, which has been linked to cancer claims.
Continue reading